Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT03322345
- Status
- Enrolling By Invitation
Conditions
- Catecholamine
- Congenital Heart Disease
- Dopamine
- Lymph
- Lymphatic System
- Protein-Losing Enteropathies
- Single-ventricle
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Patients that have undergone a Fontan procedure (surgical correction for single ventricle congenital heart disease) may develop a complication known as protein-losing enteropathy (PLE). Some studies suggest PLE is primarily caused by impaired lymph flow. Use of continuous dopamine infusion can improve PLE. Evidence suggests the effect of dopamine may be through its effect on lymphatic function. This observational study looks at markers of lymph flow and PLE symptoms after treatment using dopamine and other standard therapies during disease exacerbations.
Key Dates
- Start date
- Apr 9, 2019
- Status verified
- Mar 2025
- Primary completion
- Apr 1, 2027
- Completion
- Apr 1, 2027
Study Design
- Enrollment
- 24 participants (estimated)
Arms
- Arm: Dopamine AddedPatients with protein losing enteropathy (PLE) that have an exacerbation such that their treating physicians decide to add continuous dopamine infusion to their current therapies.
- Arm: No dopamine added (control)Patients with protein losing enteropathy (PLE) that have an exacerbation such that their treating physicians decide to add new therapies to their current therapies but that do not require the addition of continuous dopamine infusion.
Primary Outcome Measure
Change in CD4 counts [ Time Frame: Baseline to 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | - |
Find similar trials in Ann Arbor, MI
By research site
Related Studies
- ATrial Tachycardia PAcing Therapy in Congenital HeartRecruiting · Ian Law · Los Angeles, California
- Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryRecruiting · Leiden University Medical Center · Baltimore, Maryland
- Autus Valve Continued Access Study (CAS)Not Yet Recruiting · Autus Valve Technologies, Inc. · Los Angeles, California
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal DevelopmentRecruiting · Emory University · Atlanta, Georgia